Final Results of a CTEP Sponsored Phase I Study of Alistertib in Combination with Bortezomib and Rituximab in Replapsed and Refractory Mantle Cell and Low Grade Non-Hodgkin Lymphoma

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Barta Stefan Klaus; Kornblum Noah; Raphael Bruce G.; Hymes Kenneth B.; Grossbard Michael L.; Moskovits Tibor; Handorf Elizabeth; Sparano Joseph; Piekarz Richard; Diefenbach Catherine;

  展开▼
• 作者单位

  Fox Chase Canc Ctr 7701 Burholme Ave Philadelphia PA 19111 USA;

  Montefiore Med Ctr Albert Einstein Coll Med Dept Hematol &

  Oncol Bronx NY 10467 USA;

  NYU Langone Hlth New York NY USA;

  NYU Langone Hlth New York NY USA;

  NYU Langone Hlth New York NY USA;

  NYU Langone Hlth New York NY USA;

  Fox Chase Canc Ctr 7701 Burholme Ave Philadelphia PA 19111 USA;

  Montefiore Med Ctr Albert Einstein Canc Ctr Bronx NY 10467 USA;

  NCI Bethesda MD 20892 USA;

  NYU Langone Hlth NYU Perlmutter Canc Ctr New York NY USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词